Direxion Daily S&P Biotech Bull 3x Shares Rating $187.14 +1.05 (+0.56%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.71Holdings in LABU have an aggregate rating of Moderate Buy based on 292 analyst ratings issued in the past year covering 18 companies (19.9% of the portfolio).LABU Aggregate Price Target$187.14High Prediction$187.14Average Prediction$187.14Low Prediction$187.14Holdings in LABU have an aggregate price target of $187.14 and a range of $187.14 to $187.14 covering 18 companies (19.9% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 18 LABU Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.53%APLSApellis Pharmaceuticals$40.971.9638 of 5 stars2.04$34.89 -14.8%23Positive NewsUpcoming Earnings1.32%RVMDRevolution Medicines$147.21-0.5%2.8 of 5 stars3.10$78.94 -46.4%21Upcoming Earnings1.27%TVTXTravere Therapeutics$44.80-0.2%1.5338 of 5 stars2.69$46.58 4.0%13Trending NewsAnalyst ForecastInsider Trade1.14%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6361 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings1.14%ALKSAlkermes$36.25+6.1%3.818 of 5 stars2.82$44.29 22.2%17Trending NewsGap Up1.13%TWSTTwist Bioscience$56.70+0.9%1.2066 of 5 stars2.60$53.00 -6.5%10Trending NewsEarnings ReportAnalyst ForecastGap Up1.12%TGTXTG Therapeutics$36.10+1.1%3.9581 of 5 stars2.57$50.00 38.5%7Upcoming Earnings1.12%SMMTSummit Therapeutics$17.54+3.3%2.4542 of 5 stars2.59$27.58 57.3%17News CoverageEarnings ReportAnalyst Upgrade1.12%MDGLMadrigal Pharmaceuticals$502.47-3.1%2.8596 of 5 stars2.76$685.31 36.4%17Positive NewsUpcoming Earnings1.05%BEAMBeam Therapeutics$28.90-3.9%2.8931 of 5 stars2.75$49.36 70.8%161.03%APGEApogee Therapeutics$83.29-0.3%2.9252 of 5 stars2.78$112.73 35.4%18News CoverageUpcoming Earnings1.02%PRAXPraxis Precision Medicines$333.30-1.3%3.3965 of 5 stars3.00$590.78 77.3%20Positive News1.00%SRRKScholar Rock$47.13+1.4%3.4424 of 5 stars3.17$55.40 17.5%18Upcoming Earnings1.00%EXELExelixis$44.42+0.6%3.3604 of 5 stars2.39$47.00 5.8%23Positive NewsEarnings Report0.98%INCYIncyte$97.47+0.3%4.0887 of 5 stars2.43$104.26 7.0%21Earnings ReportAnalyst Forecast0.98%UTHRUnited Therapeutics$572.20-1.6%3.5587 of 5 stars2.77$601.50 5.1%13Upcoming EarningsInsider Trade0.96%MIRMMirum Pharmaceuticals$105.81+0.0%2.2543 of 5 stars2.93$125.25 18.4%14Trending NewsUpcoming EarningsAnalyst Forecast0.96%CELCCelcuity$141.69-2.3%1.3594 of 5 stars2.75$134.50 -5.1%12Trending NewsAnalyst Forecast This page (NYSEARCA:LABU) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts